Two Sigma Advisers LP bought a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm bought 27,800 shares of the healthcare conglomerate's stock, valued at approximately $14,063,000.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Western Pacific Wealth Management LP boosted its stake in UnitedHealth Group by 2.2% during the 4th quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate's stock valued at $456,000 after purchasing an additional 19 shares during the last quarter. MCF Advisors LLC grew its holdings in UnitedHealth Group by 0.8% during the fourth quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate's stock worth $1,304,000 after buying an additional 20 shares in the last quarter. Axiom Financial Strategies LLC lifted its stake in UnitedHealth Group by 3.6% during the 4th quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate's stock valued at $291,000 after acquiring an additional 20 shares in the last quarter. Richwood Investment Advisors LLC grew its stake in shares of UnitedHealth Group by 0.4% in the 4th quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock worth $2,654,000 after acquiring an additional 20 shares in the last quarter. Finally, 44 Wealth Management LLC lifted its position in shares of UnitedHealth Group by 1.6% during the fourth quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate's stock valued at $662,000 after purchasing an additional 21 shares in the last quarter. Institutional investors own 87.86% of the company's stock.
UnitedHealth Group Stock Performance
NYSE UNH opened at $303.08 on Thursday. The stock has a market capitalization of $274.93 billion, a PE ratio of 19.55, a P/E/G ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The company's 50 day simple moving average is $460.62 and its two-hundred day simple moving average is $508.74. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter in the prior year, the company earned $6.91 earnings per share. Analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.77%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio is currently 35.18%.
Analyst Ratings Changes
UNH has been the subject of several analyst reports. Raymond James lowered shares of UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research note on Wednesday, May 14th. TD Securities reissued a "hold" rating and issued a $308.00 price objective (down previously from $520.00) on shares of UnitedHealth Group in a research report on Monday. Truist Financial reiterated a "buy" rating and set a $360.00 target price (down from $580.00) on shares of UnitedHealth Group in a research note on Monday. JPMorgan Chase & Co. lowered their price objective on shares of UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating on the stock in a research report on Thursday, May 15th. Finally, TD Cowen cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price target on the stock. in a report on Monday. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $441.87.
Read Our Latest Report on UnitedHealth Group
Insider Activity at UnitedHealth Group
In other UnitedHealth Group news, Director John H. Noseworthy purchased 300 shares of the business's stock in a transaction on Wednesday, May 14th. The stock was acquired at an average cost of $312.16 per share, for a total transaction of $93,648.00. Following the completion of the transaction, the director now directly owns 6,063 shares in the company, valued at approximately $1,892,626.08. This represents a 5.21% increase in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Timothy Patrick Flynn bought 1,533 shares of the stock in a transaction dated Wednesday, May 14th. The stock was bought at an average cost of $320.80 per share, with a total value of $491,786.40. Following the purchase, the director now owns 6,033 shares in the company, valued at $1,935,386.40. The trade was a 34.07% increase in their position. The disclosure for this purchase can be found here. Insiders have bought a total of 109,408 shares of company stock valued at $31,607,768 over the last 90 days. 0.33% of the stock is owned by insiders.
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.